GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trxade Health Inc (FRA:4E40) » Definitions » Cyclically Adjusted Revenue per Share

Trxade Health (FRA:4E40) Cyclically Adjusted Revenue per Share : €0.00 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Trxade Health Cyclically Adjusted Revenue per Share?

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Trxade Health's adjusted revenue per share for the three months ended in Jun. 2024 was €0.022. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.00 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Trxade Health's average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -29.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Trxade Health was -0.80% per year. The lowest was -29.90% per year. And the median was -15.35% per year.

As of today (2024-09-23), Trxade Health's current stock price is €6.862. Trxade Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was €0.00. Trxade Health's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Trxade Health was 3.01. The lowest was 0.09. And the median was 0.87.


Trxade Health Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Trxade Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trxade Health Cyclically Adjusted Revenue per Share Chart

Trxade Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 35.83 39.28 0.01 -

Trxade Health Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.97 14.88 - - -

Competitive Comparison of Trxade Health's Cyclically Adjusted Revenue per Share

For the Pharmaceutical Retailers subindustry, Trxade Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trxade Health's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Trxade Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Trxade Health's Cyclically Adjusted PS Ratio falls into.



Trxade Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Trxade Health's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.022/132.5538*132.5538
=0.022

Current CPI (Jun. 2024) = 132.5538.

Trxade Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 0.878 100.428 1.159
201412 1.387 99.070 1.856
201503 1.853 99.621 2.466
201506 2.997 100.684 3.946
201509 4.205 100.392 5.552
201512 -1.546 99.792 -2.054
201603 1.659 100.470 2.189
201606 1.494 101.688 1.947
201609 1.550 101.861 2.017
201612 1.719 101.863 2.237
201703 1.832 102.862 2.361
201706 1.766 103.349 2.265
201709 1.631 104.136 2.076
201712 1.763 104.011 2.247
201803 1.831 105.290 2.305
201806 1.872 106.317 2.334
201809 1.881 106.507 2.341
201812 2.871 105.998 3.590
201903 3.348 107.251 4.138
201906 4.198 108.070 5.149
201909 5.206 108.329 6.370
201912 3.508 108.420 4.289
202003 4.028 108.902 4.903
202006 11.594 108.767 14.130
202009 9.993 109.815 12.062
202012 3.035 109.897 3.661
202103 4.750 111.754 5.634
202106 2.911 114.631 3.366
202109 3.985 115.734 4.564
202112 3.884 117.630 4.377
202203 5.398 121.301 5.899
202206 5.692 125.017 6.035
202209 3.763 125.227 3.983
202212 3.441 125.222 3.642
202303 0.686 127.348 0.714
202306 0.498 128.729 0.513
202309 0.816 129.860 0.833
202312 2.634 129.419 2.698
202403 0.000 131.776 0.000
202406 0.022 132.554 0.022

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Trxade Health  (FRA:4E40) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Trxade Health was 3.01. The lowest was 0.09. And the median was 0.87.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Trxade Health Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Trxade Health's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Trxade Health Business Description

Traded in Other Exchanges
Address
2420 Brunello Trace., Lutz, FL, USA, 33558
Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its product and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Community Specialty Pharmacy, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.

Trxade Health Headlines

No Headlines